Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_assertion type Assertion NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_head.
- NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_assertion description "[Furthermore, a considerable correlation was observed between ERCC1 rs11615 and the response rate of esophageal cancer patients to neoadjuvant therapy (OR = 0.228, 95% CI = 0.125-0.418, heterogeneity P = 0.291).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_provenance.
- NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_assertion evidence source_evidence_literature NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_provenance.
- NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_assertion SIO_000772 26426637 NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_provenance.
- NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_assertion wasDerivedFrom befree-2016 NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_provenance.
- NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_assertion wasGeneratedBy ECO_0000203 NP1294596.RA4u1jy6M_BYcvGhL1JbcVHsglpWpgY-kttKJKDCcvGZM130_provenance.